Core Viewpoint - The company has successfully achieved small-scale supply of its modified polymer materials business, which includes various types of modified plastics used in multiple industries [1] Group 1: Product Overview - The main products of the modified polymer materials business include modified polypropylene (PP), modified polystyrene (ABS), and modified engineering plastics, along with others such as modified PA6 and PEEK [1] - These products are primarily applied in sectors such as automotive parts, electronics, aerospace, defense, power and energy storage systems, charging stations, 5G, medical, and robotics [1] Group 2: Production Capacity - The company has established a pilot production base in Qingdao with an annual production capacity of 30,000 tons [1] - The modified materials business has commenced small-scale supply, although the products have not yet been utilized in low-altitude flying vehicles [1]

Group 1: Financial Performance - In 2024, the company achieved operating revenue of 67,885.20 million CNY, an increase of 18.59% year-on-year [3] - Revenue from products used in new energy vehicles reached 16,556.37 million CNY, up 126.21%, accounting for 24.39% of total revenue [3] - The net profit attributable to shareholders was 1,575.60 million CNY, a decrease of 32.34% compared to the previous year [3] Group 2: Order and Production Capacity - As of the end of 2024, the company had new injection mold orders worth 8.52 billion CNY, a year-on-year increase of 26.97% [5] - The company’s production capacity for molds in 2024 was approximately 1,000 sets, with an actual output of 735 sets, resulting in a capacity utilization rate of 73.5% [4] - By the end of 2024, the company had a backlog of injection mold orders worth 9.38 billion CNY, a 22.57% increase year-on-year [5] Group 3: Future Projects and Investments - The second phase of the Thailand factory is expected to be operational by August 2025, with an anticipated additional output value of around 100 million CNY [6] - The company plans to distribute cash dividends of 3 CNY per 10 shares, totaling 25,427,100 CNY, with a distribution ratio of 161.38% [6] - The company’s modified materials business is projected to reach a total capacity of 150,000 tons per year by the end of 2025 [12] Group 4: Research and Development - In 2024, the company invested 28,331.20 million CNY in R&D, accounting for 4.17% of operating revenue, a 15.34% increase year-on-year [10] - The company obtained a total of 29 patents in 2024, including 19 invention patents and 10 utility model patents [10] - The company has developed several core technologies, including micro-foaming injection molding technology and high-gloss PC+ABS plastic alloy technology [11][8] Group 5: Market Position and Strategy - The company maintains a strong order backlog and stable production operations, with a focus on sustainable development and shareholder returns [4][6] - The company’s foreign sales accounted for 60.97% of total revenue in 2024, with minimal impact from trade tensions due to a concentration of customers in Europe [13] - The company differentiates itself through a "molding and plastic integration" approach, providing comprehensive solutions from mold customization to raw material supply [15]